Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Victoria Lane Thomas, M.D.

Concepts (54)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Civil Rights120091290.290 Why?
Adrenergic beta-2 Receptor Agonists320161090.260 Why?
Physician's Role120099270.190 Why?
Particle Size2201616310.190 Why?
Disabled Persons1200912080.160 Why?
Adrenal Cortex Hormones3201618800.150 Why?
Anti-Asthmatic Agents220165720.110 Why?
Asthma3201662700.100 Why?
Microspheres120157730.100 Why?
Health Services Accessibility1200955080.090 Why?
Adrenergic beta-Antagonists1201612370.090 Why?
Administration, Inhalation3201611540.070 Why?
Supreme Court Decisions120091350.070 Why?
Glucocorticoids1201521320.060 Why?
Prejudice120095670.060 Why?
Stroke Volume1201655960.050 Why?
Heart Failure22016118400.050 Why?
Disability Evaluation1200918200.050 Why?
Pulmonary Disease, Chronic Obstructive1201632470.050 Why?
Beclomethasone12016380.030 Why?
Pregnenediones12016290.030 Why?
Databases, Factual3201680670.030 Why?
Drug Therapy, Combination2201663090.030 Why?
Muscarinic Antagonists120161330.030 Why?
Drug Utilization Review120162480.030 Why?
Drug Dosage Calculations120151160.030 Why?
Polypharmacy120163060.030 Why?
Bronchodilator Agents120165140.030 Why?
Delayed-Action Preparations120159670.020 Why?
Netherlands1201622770.020 Why?
Comparative Effectiveness Research120157140.020 Why?
Angiotensin Receptor Antagonists1201610610.020 Why?
Angiotensin-Converting Enzyme Inhibitors1201615140.020 Why?
Cohort Studies32016416490.020 Why?
Guideline Adherence1201622430.020 Why?
Dose-Response Relationship, Drug12015107290.010 Why?
Logistic Models12016132660.010 Why?
United States12009729030.010 Why?
Primary Health Care1201647360.010 Why?
Practice Guidelines as Topic1201674250.010 Why?
Treatment Outcome22016651880.010 Why?
Humans520167659680.010 Why?
Disease Progression12015136320.010 Why?
Male420163636980.010 Why?
Female420163961120.010 Why?
Time Factors12016400650.010 Why?
Follow-Up Studies12015391930.010 Why?
Child, Preschool12015425000.010 Why?
Middle Aged220162230090.010 Why?
Adult220162230440.010 Why?
Aged, 80 and over12016594890.010 Why?
Retrospective Studies12016815140.000 Why?
Child12015805640.000 Why?
Aged120161711170.000 Why?
Thomas's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (54)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.